Clinical trials
Phase 3 Hyperlipidemias trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2013 | 8 |
| 2016 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| Pfizer | 4 |
| Takeda | 4 |
| Novartis Pharmaceuticals | 3 |
| Solvay Pharmaceuticals | 2 |
| 89bio, Inc. | 1 |
| Bayer | 1 |
| Esperion Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 21 |
| Hypercholesterolemia | 10 |
| Dyslipidemias | 5 |
| Cardiovascular Diseases | 4 |
| Aortic Valve Stenosis | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Heart Failure | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.